<SEC-DOCUMENT>0001760460-23-000005-index.html : 20230607
<SEC-HEADER>0001760460-23-000005.hdr.sgml : 20230607
<ACCEPTANCE-DATETIME>20230607205758
ACCESSION NUMBER:		0001760460-23-000005
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230607
DATE AS OF CHANGE:		20230607

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bellerophon Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001600132
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473116175
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36845
		FILM NUMBER:		231000456

	BUSINESS ADDRESS:	
		STREET 1:		184 LIBERTY CORNER ROAD, SUITE 302
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-574-4770

	MAIL ADDRESS:	
		STREET 1:		184 LIBERTY CORNER ROAD, SUITE 302
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bellerophon Therapeutics LLC
		DATE OF NAME CHANGE:	20140213

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Puissance Life Science Opportunities Fund VI
		CENTRAL INDEX KEY:			0001760460
		IRS NUMBER:				320567422
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		950 THIRD AVENUE
		STREET 2:		FL 25
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2128783702

	MAIL ADDRESS:	
		STREET 1:		950 THIRD AVENUE
		STREET 2:		FL 25
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>